Medico Intercontinental consolidated net profit rises 52.63% in the March 2022 quarter

Medico Intercontinental consolidated net profit rises 8.82% in the September 2021 quarter

The creamy layer - amongst the top performing stocks

Seems to be overvalued vs the market average

Strong financials and growth story over the years

Showing good signs of profitability & efficiency

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Good time to consider, stock is not in the overbought zone

Medico Intercontinental Ltd is engaged in the trading of pharmaceutical products